PLXNA2 and metastatic neoplasm: The rest of the PLXNs, i.e., PLXNA2, A4, B1, and B2 were overall either down-regulated or insignificantly differentially expressed in cancer tumors, but all had more decreased expression in metastatic tumors than in primary tumors.